Boxer Capital as of Sept. 30, 2016
Portfolio Holdings for Boxer Capital
Boxer Capital holds 28 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Clovis Oncology | 16.2 | $36M | 1.0M | 36.05 | |
| Medicines Company | 11.8 | $26M | 700k | 37.74 | |
| Blueprint Medicines (BPMC) | 9.4 | $21M | 705k | 29.70 | |
| Medicines | 9.3 | $21M | 550k | 37.74 | |
| Beigene (ONC) | 6.8 | $15M | 494k | 30.81 | |
| Seattle Genetics | 5.6 | $13M | 233k | 54.01 | |
| Avexis | 5.5 | $12M | 300k | 41.21 | |
| Aquinox Pharmaceuticals | 5.3 | $12M | 878k | 13.36 | |
| Incyte Corporation (INCY) | 4.2 | $9.4M | 100k | 94.29 | |
| BioMarin Pharmaceutical (BMRN) | 4.2 | $9.3M | 100k | 92.52 | |
| Aradigm | 2.9 | $6.4M | 931k | 6.88 | |
| Acadia Pharmaceuticals | 2.9 | $6.4M | 201k | 31.81 | |
| Mirati Therapeutics | 2.2 | $5.0M | 758k | 6.61 | |
| Rigel Pharmaceuticals | 2.2 | $5.0M | 1.4M | 3.67 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $3.6M | 234k | 15.16 | |
| Tesaro | 1.6 | $3.5M | 35k | 100.23 | |
| Heron Therapeutics (HRTX) | 1.5 | $3.4M | 200k | 17.23 | |
| Kura Oncology (KURA) | 1.5 | $3.3M | 533k | 6.25 | |
| Aldeyra Therapeutics (ALDX) | 1.0 | $2.3M | 291k | 7.85 | |
| Eleven Biotherapeutics | 0.9 | $2.1M | 750k | 2.80 | |
| Eiger Biopharmaceuticals | 0.8 | $1.9M | 138k | 13.39 | |
| Array BioPharma | 0.6 | $1.4M | 200k | 6.75 | |
| Nabriva Therapeutics | 0.6 | $1.2M | 177k | 7.05 | |
| Akari Therapeutics | 0.5 | $1.2M | 140k | 8.51 | |
| Onconova Therapeutics | 0.4 | $838k | 316k | 2.65 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.3 | $643k | 155k | 4.15 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.1 | $242k | 242k | 1.00 | |
| Essa Pharma | 0.0 | $74k | 28k | 2.63 |
